CJC-1295: The Gold Standard GHRH Analog for Growth Hormone Research

Understanding CJC-1295: More Than Just a Growth Hormone Peptide

CJC-1295 represents one of the most significant advances in growth hormone releasing hormone (GHRH) research technology. Unlike natural GHRH, which has an extremely short half-life of approximately 7 minutes due to rapid enzymatic degradation, CJC-1295 incorporates Drug Affinity Complex (DAC) technology that extends its biological activity to 6-8 days.

This remarkable extension transforms growth hormone research possibilities, allowing investigators to study sustained growth hormone release patterns that more closely mimic natural physiological responses rather than the pharmacological spikes produced by synthetic growth hormone injections.

Our CJC-1295 showcases why Planet Peptide has become the trusted choice for researchers focused on extended-release growth hormone studies.

The Science Behind CJC-1295’s Extended Activity

Drug Affinity Complex Technology

The revolutionary aspect of CJC-1295 lies in its molecular modification through Drug Affinity Complex technology. This involves the covalent attachment of a reactive lysine residue that binds to endogenous albumin in the bloodstream, creating a stable peptide-albumin complex.

Mechanism of Extended Release:

1. Albumin Binding: CJC-1295 forms covalent bonds with circulating albumin
2. Protection from Degradation: The albumin shield protects against dipeptidyl peptidase-4 (DPP-4) and other proteases
3. Sustained Release: Gradual dissociation maintains consistent GHRH activity
4. Natural Clearance: Eventually metabolized through normal albumin turnover

This technology doesn’t just extend the peptide’s life—it fundamentally changes how growth hormone is released, creating a more physiological pattern that researchers can study over extended periods.

CJC-1295 vs. Traditional GHRH: A Research Comparison

Why This Matters for Researchers

The extended half-life of CJC-1295 enables research applications that were previously impossible with natural GHRH:

Long-Term Growth Studies: Investigate growth hormone’s role in tissue development over weeks rather than hours

Metabolic Research: Study sustained metabolic changes that occur with consistent growth hormone elevation

Aging Research: Examine how prolonged growth hormone stimulation affects age-related processes

Sleep Pattern Studies: Investigate growth hormone’s relationship with sleep cycles over multiple weeks

Molecular Architecture and Specifications

Structural Modifications

CJC-1295 is based on the first 29 amino acids of GHRH but incorporates four critical substitutions:

• Position 2: Alanine → D-Alanine (increased stability)
• Position 8: Alanine → Glutamine (enhanced receptor binding)
• Position 15: Alanine → Leucine (improved potency)
• Position 27: Lysine → Lysine-DAC (albumin binding)

Sequence: Tyr-D-Ala-Asp-Ala-Ile-Phe-Thr-Gln-Ser-Tyr-Arg-Lys-Val-Leu-Ala-Gln-Leu-Ser-Ala-Arg-Lys-Leu-Leu-Gln-Asp-Ile-Lys(DAC)-Arg-Gln-Gln-Gly-Glu-Ser-Asn-Gln-Glu-Arg-Gly-Ala-Arg-Ala-Arg-Leu-NH2

Molecular Formula: C₁₆₅H₂₆₉N₄₇O₄₆
Molecular Weight: 3647.15 Da
Purity: 99.6%+ (HPLC verified)
Appearance: White to off-white lyophilized powder

Research Applications: Beyond Basic Growth Hormone Studies

Advanced Molecular Research

GHRH Receptor Pharmacology: CJC-1295’s extended activity allows detailed investigation of GHRH receptor desensitization, recycling, and long-term signaling cascade effects that cannot be studied with short-acting compounds.

IGF-1 Axis Investigation: Research the complex relationship between sustained growth hormone elevation and IGF-1 production, including tissue-specific responses and temporal patterns.

Hypothalamic-Pituitary Function: Study how prolonged GHRH stimulation affects feedback mechanisms, somatostatin release, and overall hypothalamic-pituitary-growth hormone axis regulation.

Exercise Physiology Applications

Training Adaptation Studies: Investigate how sustained growth hormone elevation affects muscle protein synthesis, exercise recovery, and adaptation to training stimuli over extended periods.

Body Composition Research: Examine changes in lean mass, fat distribution, and metabolic parameters during prolonged growth hormone stimulation protocols.

Performance Recovery Investigation: Study the role of extended growth hormone elevation in recovery from exercise-induced muscle damage and metabolic stress.

Aging and Longevity Research

Age-Related Growth Hormone Decline: CJC-1295 allows researchers to model growth hormone replacement in aging subjects, investigating effects on muscle mass, bone density, cognitive function, and overall healthspan.

Cellular Regeneration Studies: Extended growth hormone elevation enables investigation of tissue repair, cellular turnover, and regenerative processes that require weeks to months to fully manifest.

Sleep Quality and Recovery: Research the relationship between sustained growth hormone levels and sleep architecture, recovery patterns, and circadian rhythm optimization.

Quality Control: Pharmaceutical-Grade Manufacturing

Multi-Stage Purification Process

Our CJC-1295 undergoes rigorous purification to achieve pharmaceutical-grade quality:

1. Solid-Phase Peptide Synthesis (SPPS)
   • Automated synthesis with real-time monitoring
   • High-purity amino acid building blocks
   • Optimized coupling conditions
2. High-Performance Liquid Chromatography (HPLC)
   • Reverse-phase purification
   • Multiple purification passes
   • Fraction analysis and pooling
3. Lyophilization Process
   • Controlled freeze-drying
   • Optimal cake formation
   • Moisture content verification

Comprehensive Analytical Panel

Every batch undergoes extensive testing:

Storage Optimization and Stability Data

Long-Term Stability Profile

CJC-1295’s stability has been extensively characterized under various conditions:

Storage Condition          Stability Duration    Degradation Rate
-80°C (ultra-low freezer)  >5 years             <0.1%/year
-20°C (standard freezer)   >3 years             <0.2%/year
4°C (refrigerated)         6-12 months          <1.0%/month
25°C (room temperature)    2-4 weeks            2-5%/week
37°C (body temperature)    3-7 days             5-10%/day

Reconstitution Stability

Post-reconstitution stability varies by solvent and storage conditions:

Bacteriostatic Water (0.9% benzyl alcohol):

• 4°C: 4-6 weeks (recommended)
• 25°C: 5-7 days
• 37°C: 24-48 hours

Sterile Water for Injection:

• 4°C: 2-3 weeks
• 25°C: 2-3 days
• 37°C: 12-24 hours

Research Protocol Considerations

Dosing Strategy for Research

CJC-1295’s extended half-life requires different dosing considerations compared to other growth hormone secretagogues:

Saturation Dosing: Due to albumin binding capacity, there’s a saturation point beyond which additional CJC-1295 doesn’t increase efficacy. Research protocols typically use 2-3 doses per week rather than daily administration.

Timing Considerations: Unlike growth hormone releasing peptides that require specific timing relative to meals and sleep, CJC-1295’s sustained release makes timing less critical, simplifying research protocols.

Combination Studies: CJC-1295 is frequently combined with growth hormone releasing peptides (GHRPs) like Ipamorelin to study synergistic effects on growth hormone release patterns.

Research Support and Documentation

Scientific Literature Database

Access to comprehensive research database including:

• Peer-reviewed publications on CJC-1295
• Comparative studies with other GHRH analogs
• Protocol optimization guidelines
• Safety and efficacy data

Technical Support Services

• Protocol design consultation
• Dosing strategy optimization
• Study timeline planning
• Data interpretation assistance
• Regulatory compliance guidance

Quality Documentation Package

• Certificate of Analysis with each shipment
• Stability data and storage recommendations
• Handling and reconstitution protocols
• Safety data sheets
• Regulatory compliance documentation

Product Availability and Ordering

Standard Research Quantities

• 1mg vials: Pilot studies and protocol optimization
• 2mg vials: Standard research applications
• 5mg vials: Extended studies and bulk research
• 10mg vials: Large-scale research programs

Custom Formulations

• Modified release formulations
• Combination research products
• Specialized concentrations
• Custom analytical services

CJC-1295 represents the pinnacle of GHRH analog technology, offering researchers unprecedented opportunities to investigate growth hormone physiology over extended timeframes. Its unique pharmacological profile makes it an indispensable tool for advanced growth hormone research.

This product is intended for research use only and is not for human consumption.